The Systemic Oral Azoles are the drugs which belong to azole class. The azole class drugs have a nitrogen in their structure i.e. aza. Hence they known as azoles. Systemic oral azoles include drugs such as, fluconazole, ketoconazole, Iitraconazole etc. Among these drugs fluconazole has best pharmacological action with lesser side effects and Iitraconazole is suitable for long term treatment. These drugs are the best alternatives for other antibiotics to treat mycoses. Systemic oral azoles are commonly used to treat different forms of mycoses, sporotrichosis, fungal meningitis, candida syndrome, and aspergillosis.
MARKET DYNAMICS
The key market drivers for Systemic Oral Azoles Market Includes, rising incidences of fungal infections globally due to unhygienic conditions and lifestyle. Additionally, overuse of antibiotics, steroids also cause aspergillosis and candidiasis which is expected to drive market growth. Moreover, rising R&D expenditures by pharmaceutical companies is also expected to fuel market growth during the forecast period. However, possible side effects from treatment and high cost of treatment course is expected to have a negative impact on market growth.
MARKET SCOPE
The "Systemic Oral Azoles Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Systemic Oral Azoles market with detailed market segmentation by drug type, application. The Systemic Oral Azoles Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Systemic Oral Azoles Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Systemic Oral Azoles Market is segmented on the basis of drug type, application. On the basis of drug type the market is segmented as, voriconazole, Iitraconazole, fluconazole, ketoconazole and miconazole. And on the basis of application the market is segmented as, candidiasis, thrush, yeast infection, seborrheic dermatitis.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Systemic Oral Azoles Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Systemic Oral Azoles Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Systemic Oral Azoles Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Systemic Oral Azoles Market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Systemic Oral Azoles Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Systemic Oral Azoles Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Systemic Oral Azoles Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Systemic Oral Azoles Market in these regions.
MARKET PLAYERS
The report covers key developments in the Systemic Oral Azoles Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Systemic Oral Azoles Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Systemic Oral Azoles market in the global market. Below mentioned is the list of few companies engaged in the Systemic Oral Azoles Market.
The report also includes the profiles of key players in Systemic Oral Azoles Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Novartis AG
- Sanofi-Aventis
- Pfizer, Inc
- Merck and Company,Inc
- Enzon Pharmaceuticals,Inc
- Bayer AG
- Astellas Pharma,Inc
- GlaxoSmithKline, Plc
- Abbott
- Cipla
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Systemic Oral Azoles Market - By Drug type
1.3.2 Systemic Oral Azoles Market - By Application
1.3.3 Systemic Oral Azoles Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SYSTEMIC ORAL AZOLES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SYSTEMIC ORAL AZOLES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SYSTEMIC ORAL AZOLES MARKET - GLOBAL MARKET ANALYSIS
6.1. SYSTEMIC ORAL AZOLES - GLOBAL MARKET OVERVIEW
6.2. SYSTEMIC ORAL AZOLES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SYSTEMIC ORAL AZOLES MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. VORICONAZOLE
7.3.1. Overview
7.3.2. Voriconazole Market Forecast and Analysis
7.4. ITRACONAZOLE
7.4.1. Overview
7.4.2. itraconazole Market Forecast and Analysis
7.5. FLUCONAZOLE
7.5.1. Overview
7.5.2. fluconazole Market Forecast and Analysis
7.6. KETOCONAZOLE
7.6.1. Overview
7.6.2. ketoconazole Market Forecast and Analysis
7.7. MICONAZOLE
7.7.1. Overview
7.7.2. miconazole Market Forecast and Analysis
8. SYSTEMIC ORAL AZOLES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CANDIDIASIS
8.3.1. Overview
8.3.2. Candidiasis Market Forecast and Analysis
8.4. THRUSH
8.4.1. Overview
8.4.2. Thrush Market Forecast and Analysis
8.5. YEAST INFECTION
8.5.1. Overview
8.5.2. Yeast Infection Market Forecast and Analysis
8.6. SEBORRHEIC DERMATITIS
8.6.1. Overview
8.6.2. seborrheic dermatitis Market Forecast and Analysis
9. SYSTEMIC ORAL AZOLES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Systemic Oral Azoles Market Overview
9.1.2 North America Systemic Oral Azoles Market Forecasts and Analysis
9.1.3 North America Systemic Oral Azoles Market Forecasts and Analysis - By Drug type
9.1.4 North America Systemic Oral Azoles Market Forecasts and Analysis - By Application
9.1.5 North America Systemic Oral Azoles Market Forecasts and Analysis - By Countries
9.1.5.1 United States Systemic Oral Azoles Market
9.1.5.1.1 United States Systemic Oral Azoles Market by Drug type
9.1.5.1.2 United States Systemic Oral Azoles Market by Application
9.1.5.2 Canada Systemic Oral Azoles Market
9.1.5.2.1 Canada Systemic Oral Azoles Market by Drug type
9.1.5.2.2 Canada Systemic Oral Azoles Market by Application
9.1.5.3 Mexico Systemic Oral Azoles Market
9.1.5.3.1 Mexico Systemic Oral Azoles Market by Drug type
9.1.5.3.2 Mexico Systemic Oral Azoles Market by Application
9.2. EUROPE
9.2.1 Europe Systemic Oral Azoles Market Overview
9.2.2 Europe Systemic Oral Azoles Market Forecasts and Analysis
9.2.3 Europe Systemic Oral Azoles Market Forecasts and Analysis - By Drug type
9.2.4 Europe Systemic Oral Azoles Market Forecasts and Analysis - By Application
9.2.5 Europe Systemic Oral Azoles Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Systemic Oral Azoles Market
9.2.5.1.1 Germany Systemic Oral Azoles Market by Drug type
9.2.5.1.2 Germany Systemic Oral Azoles Market by Application
9.2.5.2 France Systemic Oral Azoles Market
9.2.5.2.1 France Systemic Oral Azoles Market by Drug type
9.2.5.2.2 France Systemic Oral Azoles Market by Application
9.2.5.3 Italy Systemic Oral Azoles Market
9.2.5.3.1 Italy Systemic Oral Azoles Market by Drug type
9.2.5.3.2 Italy Systemic Oral Azoles Market by Application
9.2.5.4 Spain Systemic Oral Azoles Market
9.2.5.4.1 Spain Systemic Oral Azoles Market by Drug type
9.2.5.4.2 Spain Systemic Oral Azoles Market by Application
9.2.5.5 United Kingdom Systemic Oral Azoles Market
9.2.5.5.1 United Kingdom Systemic Oral Azoles Market by Drug type
9.2.5.5.2 United Kingdom Systemic Oral Azoles Market by Application
9.2.5.6 Rest of Europe Systemic Oral Azoles Market
9.2.5.6.1 Rest of Europe Systemic Oral Azoles Market by Drug type
9.2.5.6.2 Rest of Europe Systemic Oral Azoles Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Systemic Oral Azoles Market Overview
9.3.2 Asia-Pacific Systemic Oral Azoles Market Forecasts and Analysis
9.3.3 Asia-Pacific Systemic Oral Azoles Market Forecasts and Analysis - By Drug type
9.3.4 Asia-Pacific Systemic Oral Azoles Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Systemic Oral Azoles Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Systemic Oral Azoles Market
9.3.5.1.1 Australia Systemic Oral Azoles Market by Drug type
9.3.5.1.2 Australia Systemic Oral Azoles Market by Application
9.3.5.2 China Systemic Oral Azoles Market
9.3.5.2.1 China Systemic Oral Azoles Market by Drug type
9.3.5.2.2 China Systemic Oral Azoles Market by Application
9.3.5.3 India Systemic Oral Azoles Market
9.3.5.3.1 India Systemic Oral Azoles Market by Drug type
9.3.5.3.2 India Systemic Oral Azoles Market by Application
9.3.5.4 Japan Systemic Oral Azoles Market
9.3.5.4.1 Japan Systemic Oral Azoles Market by Drug type
9.3.5.4.2 Japan Systemic Oral Azoles Market by Application
9.3.5.5 South Korea Systemic Oral Azoles Market
9.3.5.5.1 South Korea Systemic Oral Azoles Market by Drug type
9.3.5.5.2 South Korea Systemic Oral Azoles Market by Application
9.3.5.6 Rest of Asia-Pacific Systemic Oral Azoles Market
9.3.5.6.1 Rest of Asia-Pacific Systemic Oral Azoles Market by Drug type
9.3.5.6.2 Rest of Asia-Pacific Systemic Oral Azoles Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Systemic Oral Azoles Market Overview
9.4.2 Middle East and Africa Systemic Oral Azoles Market Forecasts and Analysis
9.4.3 Middle East and Africa Systemic Oral Azoles Market Forecasts and Analysis - By Drug type
9.4.4 Middle East and Africa Systemic Oral Azoles Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Systemic Oral Azoles Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Systemic Oral Azoles Market
9.4.5.1.1 South Africa Systemic Oral Azoles Market by Drug type
9.4.5.1.2 South Africa Systemic Oral Azoles Market by Application
9.4.5.2 Saudi Arabia Systemic Oral Azoles Market
9.4.5.2.1 Saudi Arabia Systemic Oral Azoles Market by Drug type
9.4.5.2.2 Saudi Arabia Systemic Oral Azoles Market by Application
9.4.5.3 U.A.E Systemic Oral Azoles Market
9.4.5.3.1 U.A.E Systemic Oral Azoles Market by Drug type
9.4.5.3.2 U.A.E Systemic Oral Azoles Market by Application
9.4.5.4 Rest of Middle East and Africa Systemic Oral Azoles Market
9.4.5.4.1 Rest of Middle East and Africa Systemic Oral Azoles Market by Drug type
9.4.5.4.2 Rest of Middle East and Africa Systemic Oral Azoles Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Systemic Oral Azoles Market Overview
9.5.2 South and Central America Systemic Oral Azoles Market Forecasts and Analysis
9.5.3 South and Central America Systemic Oral Azoles Market Forecasts and Analysis - By Drug type
9.5.4 South and Central America Systemic Oral Azoles Market Forecasts and Analysis - By Application
9.5.5 South and Central America Systemic Oral Azoles Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Systemic Oral Azoles Market
9.5.5.1.1 Brazil Systemic Oral Azoles Market by Drug type
9.5.5.1.2 Brazil Systemic Oral Azoles Market by Application
9.5.5.2 Argentina Systemic Oral Azoles Market
9.5.5.2.1 Argentina Systemic Oral Azoles Market by Drug type
9.5.5.2.2 Argentina Systemic Oral Azoles Market by Application
9.5.5.3 Rest of South and Central America Systemic Oral Azoles Market
9.5.5.3.1 Rest of South and Central America Systemic Oral Azoles Market by Drug type
9.5.5.3.2 Rest of South and Central America Systemic Oral Azoles Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. SYSTEMIC ORAL AZOLES MARKET, KEY COMPANY PROFILES
11.1. NOVARTIS AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. PFIZER,INC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. SANOFI
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. MERCK AND CO., INC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ENZON PHARMACEUTICALS, INC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BAYER AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ASTELLAS PHARMA, INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. GLAXOSMITHKLINE PLC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ABBOTT
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. CIPLA
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Novartis AG
2. Pfizer,Inc
3. Sanofi
4. Merck and Co., Inc
5. Enzon Pharmaceuticals, Inc
6. Bayer AG
7. Astellas Pharma, Inc
8. GlaxoSmithKline plc
9. Abbott
10. Cipla
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For